BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20798884)

  • 1. Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists.
    Wisser AS; Habbel P; Wiedenmann B; Klapp BF; Mönnikes H; Kobelt P
    Int J Pept; 2010; 2010():. PubMed ID: 20798884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
    Lean ME; Malkova D
    Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite-related peptides in childhood and adolescence: role of ghrelin, PYY, and GLP-1.
    Horner K; Lee S
    Appl Physiol Nutr Metab; 2015 Nov; 40(11):1089-99. PubMed ID: 26466085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise intensity on plasma concentrations of appetite-regulating hormones: Potential mechanisms.
    Hazell TJ; Islam H; Townsend LK; Schmale MS; Copeland JL
    Appetite; 2016 Mar; 98():80-8. PubMed ID: 26721721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
    Arusoglu G; Koksal G; Cinar N; Tapan S; Aksoy DY; Yildiz BO
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4475-82. PubMed ID: 24001751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.
    Saydam BO; Yildiz BO
    Curr Pharm Des; 2016; 22(36):5572-5587. PubMed ID: 27426125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-gut axis and its role in the control of food intake.
    Konturek SJ; Konturek JW; Pawlik T; Brzozowski T
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):137-54. PubMed ID: 15082874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gene expressions of ghrelin, PYY, and CCK in the gastrointestinal tract of the hyperphagic intrauterine growth restriction rat offspring.
    Nagata E; Nakagawa Y; Yamaguchi R; Fujisawa Y; Sano S; Satake E; Matsushita R; Nakanishi T; Liu Y; Ohzeki T
    Horm Metab Res; 2011 Mar; 43(3):178-82. PubMed ID: 21264794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food Intake.
    Stengel A; Taché Y
    J Neurogastroenterol Motil; 2012 Apr; 18(2):138-49. PubMed ID: 22523723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Food intake regulation -  1st part].
    Brunerová L; Anděl M
    Vnitr Lek; 2013 Sep; 59(9):808-17. PubMed ID: 24073953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal hormones and regulation of food intake.
    Dhillo WS; Bloom SR
    Horm Metab Res; 2004; 36(11-12):846-51. PubMed ID: 15655718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential involvement of lactate and interleukin-6 in the appetite-regulatory hormonal response to an acute exercise bout.
    Islam H; Townsend LK; McKie GL; Medeiros PJ; Gurd BJ; Hazell TJ
    J Appl Physiol (1985); 2017 Sep; 123(3):614-623. PubMed ID: 28684587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones.
    Parkinson JR; Dhillo WS; Small CJ; Chaudhri OB; Bewick GA; Pritchard I; Moore S; Ghatei MA; Bloom SR
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E698-708. PubMed ID: 18285527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut hormones and appetite control.
    Wren AM; Bloom SR
    Gastroenterology; 2007 May; 132(6):2116-30. PubMed ID: 17498507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gut hormones in appetite regulation (review).
    Marić G; Gazibara T; Zaletel I; Labudović Borović M; Tomanović N; Ćirić M; Puškaš N
    Acta Physiol Hung; 2014 Dec; 101(4):395-407. PubMed ID: 25532952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.